Brown Brothers Harriman & Co’s National Healthcare NHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.94M Hold
37,546
0.03% 172
2026
Q1
$6M Sell
37,546
-6,000
-14% -$921K 0.03% 182
2025
Q4
$5.97M Buy
43,546
+46
+0.1% +$5.94K 0.03% 158
2025
Q3
$5.29M Hold
43,500
0.03% 156
2025
Q2
$4.65M Hold
43,500
0.03% 162
2025
Q1
$4.04M Hold
43,500
0.03% 172
2024
Q4
$4.68M Hold
43,500
0.03% 157
2024
Q3
$5.47M Hold
43,500
0.04% 141
2024
Q2
$4.72M Hold
43,500
0.04% 150
2024
Q1
$4.11M Hold
43,500
0.03% 152
2023
Q4
$4.02M Sell
43,500
-57,500
-57% -$4.41M 0.03% 154
2023
Q3
$6.46M Sell
101,000
-7,500
-7% -$480K 0.06% 121
2023
Q2
$6.71M Hold
108,500
0.05% 110
2023
Q1
$6.3M Hold
108,500
0.05% 97
2022
Q4
$6.46M Hold
108,500
0.06% 96
2022
Q3
$6.87M Hold
108,500
0.06% 91
2022
Q2
$7.58M Hold
108,500
0.06% 91
2022
Q1
$7.62M Hold
108,500
0.05% 97
2021
Q4
$7.37M Hold
108,500
0.04% 105
2021
Q3
$7.59M Hold
108,500
0.04% 98
2021
Q2
$7.58M Buy
108,500
+1,000
+0.9% +$72.7K 0.04% 99
2021
Q1
$8.38M Sell
107,500
-121
-0.1% -$8.56K 0.05% 94
2020
Q4
$7.15M Hold
107,621
0.05% 93
2020
Q3
$6.71M Buy
107,621
+121
+0.1% +$7.57K 0.05% 87
2020
Q2
$6.82M Hold
107,500
0.05% 86
2020
Q1
$7.71M Sell
107,500
-1,775
-2% -$140K 0.06% 83
2019
Q4
$9.45M Sell
109,275
-373
-0.3% -$31.2K 0.06% 90
2019
Q3
$8.97M Sell
109,648
-50,000
-31% -$4.14M 0.06% 90
2019
Q2
$13M Buy
159,648
+2,200
+1% +$170K 0.09% 74
2019
Q1
$11.9M Buy
157,448
+350
+0.2% +$27.8K 0.08% 79
2018
Q4
$12.3M Hold
157,098
0.09% 72
2018
Q3
$11.8M Buy
157,098
+1,349
+0.9% +$99.3K 0.07% 73
2018
Q2
$11M Buy
155,749
+3,549
+2% +$232K 0.07% 71
2018
Q1
$9.08M Hold
152,200
0.05% 78
2017
Q4
$9.28M Buy
152,200
+2,200
+1% +$140K 0.05% 76
2017
Q3
$9.39M Hold
150,000
0.05% 73
2017
Q2
$10.5M Hold
150,000
0.06% 65
2017
Q1
$10.7M Hold
150,000
0.06% 67
2016
Q4
$11.4M Hold
150,000
0.06% 71
2016
Q3
$9.9M Hold
150,000
0.05% 69
2016
Q2
$9.71M Buy
150,000
+7,500
+5% +$476K 0.05% 73
2016
Q1
$8.88M Hold
142,500
0.05% 76
2015
Q4
$8.79M Hold
142,500
0.05% 79
2015
Q3
$8.68M Hold
142,500
0.04% 77
2015
Q2
$9.26M Buy
142,500
+8,500
+6% +$540K 0.04% 78
2015
Q1
$8.54M Hold
134,000
0.04% 81
2014
Q4
$8.42M Hold
134,000
0.04% 86
2014
Q3
$7.44M Hold
134,000
0.03% 91
2014
Q2
$7.54M Buy
134,000
+1,000
+0.8% +$54.4K 0.03% 92
2014
Q1
$7.42M Sell
133,000
-118,000
-47% -$6.18M 0.03% 89
2013
Q4
$13.5M Buy
251,000
+125,500
+100% +$6.42M 0.03% 89
2013
Q3
$5.93M Hold
125,500
0.03% 94
2013
Q2
$6M Buy
+125,500
New +$5.86M 0.03% 101

Other funds holding NHC

Brown Brothers Harriman & Co's NHC Position: Q2 2026 in Review

Brown Brothers Harriman & Co held its National Healthcare (NHC) position steady in Q2 2026 at 37,546 shares worth $7.94M. The position accounts for 0.03% of the portfolio, ranked #172.

Brown Brothers Harriman & Co first reported a position in NHC in Q2 2013 and has held it in 53 quarters since. The position peaked at $13.5M in Q4 2013. 248 funds tracked by Wall St. Rank hold NHC as of Q2 2026.

  • Brown Brothers Harriman & Co held 37,546 shares of National Healthcare worth $7.94M as of Q2 2026.
  • Brown Brothers Harriman & Co left its National Healthcare share count unchanged in Q2 2026.
  • National Healthcare made up 0.03% of Brown Brothers Harriman & Co's portfolio in Q2 2026, its #172 holding.
  • Brown Brothers Harriman & Co first reported a position in National Healthcare in Q2 2013 and has held it in 53 quarters since.
  • Brown Brothers Harriman & Co's National Healthcare position peaked at $13.5M in Q4 2013.
  • 248 funds tracked by Wall St. Rank held National Healthcare as of Q2 2026.

Based on Brown Brothers Harriman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.